Grants

Novel non-opioid analgesics

(2018–2020) NHMRC Development Grant

The impact of extracorporeal membrane oxygenation (ECMO) on the activities of drug enzymes that affect the pharmacokinetics and therapeutic outcomes of clinically important drugs

(2017–2018) Prince Charles Hospital Foundation

Novel prolonged-release polymeric microparticles for relief of intractable cancer-related pain

(2016–2018) NHMRC Project Grant

Novel Pain therapeutics discovery: Probing molecular mechanisms

(2016) NHMRC Equipment Grant

ACRF Facility for Molecular Imaging Agents in Cancer (AFMIAC)

(2015–2022) Australian Cancer Research Foundation

INK-004 Preliminary assessment of the analgesic efficacy of one test item following intrathecal bolus administration in a rat model of peripheral neuropathic pain

(2015–2016) UniQuest Pty Ltd

Novel analgesics for improved relief of cancer induced bone pain

(2015) UQ Collaboration and Industry Engagement Fund

Developing subtype-selective blockers of acid-sensing ion channels for treating peripheral pain

(2014–2017) NHMRC Project Grant

Translating Health Discovery (THD) - NCRIS 2013/2015/2016-17 (administered by Therapeutic Innovation Australia (TIA))

(2014–2017) Therapeutic Innovation Australia Limited

PHG-003 - Preparation of manuscript encompassing the data generated in studies PHG-001 and PHG-002 for publication in an international peer-reviewed journal

(2014–2015) UniQuest Pty Ltd

Efficacy Profiling Innovation in Novel Pain Therapeutics Discovery

(2013–2016) ARC Linkage Projects

Investigations into the pain relief properties of Komipharm's test compound

(2013–2016) UniQuest Pty Ltd

Oral EMA401 mode of action study in a rat model of post-herpetic neralgia (PHN)

(2013–2015) Spinifex Pharmaceuticals Pty Ltd

High throughput electrophysiology platform

(2013) UQ Major Equipment and Infrastructure

Translating health discoveries into products

(2011–2015) Queensland Government Smart Futures Co-Investment Fund

Therapeutic Innovation Australia - Queensland node (Source of funds: EIF)

(2011–2014) Therapeutic Innovation Australia Limited

Development of chaperonin 10-based second generation biopharmaceuticals for treatment of inflammatory diseases

(2010–2013) ARC Linkage Projects

Novel polymeric microparticles for slow-release intrathecal delivery of analgesics

(2010–2013) ARC Linkage Projects

Development of high throughput in-vitro test methods for screening sensitization potential of industrial chemicals

(2010–2012) UQ Collaboration and Industry Engagement Fund

Cost effective acquisition of an LC-MS/MS system to support CIPDD organics analysis and preclinical and clinical operations

(2010) UQ Major Equipment and Infrastructure

High content imaging analysis for bioactive and novel therapeutic target evaluation

(2010) UQ Major Equipment and Infrastructure

Alzheimer's disease: Novel MRI Biomarkers for Clinical Diagnosis and Translational Studies

(2009–2013) Queensland Government Smart State National and International Research Alliances Program

Systematic evaluation of whether in vitro methods can predict in vivo opioid analgesic efficacy, safety and teolerability

(2009–2010) Alchemia Pty Ltd

Investigation of the relationship between cytokine levels and opioid analgesics in patients with chronic non-cancer pain receiving long term intrathecal opioid therapy for pain management

(2008) Gallipoli Research Foundation

Novel therapeutic for treating painful diabetic neuropathy

(2008) Diabetes Australia Research Trust

Systematic evaluation of whether in vitro methods can predict in vivo opioid analgesic efficacy, safety and tolerability

(2006–2009) ARC Linkage Projects

Investigation of whether a small dose of Oxycodone enhances the efficacy and/or tolerability of orally administered pregabalin in patients with either post-herpetic neuralgia (PHN) or painful diabetic

(2006–2007) Gallipoli Research Foundation

Advanced Cell Labelling and Imaging Facility

(2006) ARC Linkage Infrastructure, Equipment and Facilities

NHMRC_Equipment Grant = DSI Telemetry System

(2005) NHMRC Equipment Grant

NHMRC_Equipment Grant_HLTH_Pharmacy

(2004–2005) NHMRC Equipment Grant

The analgesic evaluation of novel natural products from the Australian plant Barringtonia acutangula

(2004–2005) Griffith University

Malvern Zetasizer 3000HS

(2003) NHMRC Equipment Grant

Pharmacological investigation of the toxicological effects of high doses of systemic morphine

(2002–2003) Queensland Cancer Fund

Lipid and liposaccharide based drug delivery systems

(2001–2004) Wellcome Trust

Prevention of chronic complications in the STZ-diabetic rat

(2001–2002) Mayne Bequest Fund

A biohazard laminar flow hood for neuronal cell cultures:partial cost recovery from emergency purchase

(2001) Brain Research Fund

Efficacy of oxycodone for relief of neuropathic pain

(2000) Pharmaceutical Society of Australia

Efficacy of oxycodone relative to morphine for the relief of neuropathic pain in rats

(2000) Brain Research Fund

A novel liposaccharide based system for drug/peptide delivery

(1999–2002) Wellcome Trust

The use of fluorescence microscopy to investigate the role of the calcium pump in disease and the mechanism of excitatory side effects by high dose morphine

(1999) Ramaciotti Foundation

M3G: Further Studies of its CNS Pharmacology

(1998–2000) NHMRC Project Grant

Further investigation of morphine 3-glucuronide's role in the dose-limiting excitatory side-effects of morphine administered chronically to cancer patients

(1998–1999) Queensland Cancer Fund

Evaluating morphine for intra-articular analgesia in dogs using forceplate platform technology

(1996) John & Mary Kibble Trust

Functional characterisation of opioid binding sites in rat airways

(1996) ARC Australian Research Council (Small grants)

Investigation of the CNS mechanisms involved in the excitatory side-effects of Morphine in cancer pain management

(1995–1997) Queensland Cancer Fund

Sustained release of novel injectable analgesic agents - a pharmacological evaluation in rats

(1995) ARC Australian Research Council (Small grants)